Philip Pjura

Binding of Hoechst 33258 to the minor groove of B-DNA.

An X-ray crystallographic structure analysis has been carried out on the complex between the antibiotic and DNA fluorochrome Hoechst 33258 and a synthetic B-DNA dodecamer of sequence C-G-C-G-A-A-T-T-C-G-C-G. The drug molecule, which can be schematized as: phenol-benzimidazole-benzimidazole-piperazine, sits within the minor groove in the A-T-T-C region of the DNA double helix, displacing the spine of hydration that is found in drug-free DNA. The NH groups of the benzimidazoles make bridging three-center hydrogen bonds between adenine N-3 and thymine O-2 atoms on the edges of base-pairs, in a manner both mimicking the spine of hydration and calling to mind the binding of the auti-tumor drug netropsin. Two conformers of Hoechst are seen in roughly equal populations, related by 180 degrees rotation about the central benzimidazole-benzimidazole bond: one form in which the piperazine ring extends out from the surface of the double helix, and another in which it is buried deep within the minor groove. Steric clash between the drug and DNA dictates that the phenol-benzimidazole-benzimidazole portion of Hoechst 33258 binds only to A.T regions of DNA, whereas the piperazine ring demands the wider groove characteristic of G.C regions. Hence, the piperazine ring suggests a possible G.C-reading element for synthetic DNA sequence-reading drug analogs.

The effect of crystal packing on oligonucleotide double helix structure.

One of the questions that constantly is asked regarding x-ray crystal structure analyses of macromolecules is: To what extent is the observed crystal structure representative of the molecular conformation when free in solution, and to what degree is the structure perturbed by intermolecular crystal forces? This can be assessed with DNA oligomers because of an unusual aspect of crystallization self-complementary oligomers should possess a twofold symmetry axis normal to their helix axis, yet more often than not crystal of such oligomers do not use this internal symmetry. The two ends of the helix are crystallographically distinct though chemically identical. Complexes of DNA oligomers with intercalating drugs such as triostin A tend to use their twofold symmetry when they crystallize, whereas complexes with non-intercalating, groove-binding drugs ignore this symmetry unless the drug molecule is very small. A detailed examination of crystal packing in the dodecamer C-G-C-G-A-A-T-T-C-G-C-G provides an explanation of all of the foregoing behavior in terms of the mechanism of nucleation of DNA or DNA-drug complexes on the surface of a growing crystal. Asymmetry of the ends of the DNA helix is the price that is paid for efficient lateral packing of helices within the crystal. The actual end-for-end variation in standard helix parameters is compared with the experimental noise level as gauged by independent re-refinement of the same oligonucleotide structure where available, and with the observed extent of variation of these same parameters along the helix. Oligomers analyzed are the B-DNA dodecamer C-G-C-G-A-A-T-T-C-G-C-G, the A-DNA octamer G-G-T-A-T-A-C-C, and the phosphorothioate analogue of the B-DNA hexamer G-C-G-C-G-C. End-for-end variation, presumably the result of crystal packing is typically double the experimental noise level, and half the variation in the same parameter along the helix. Analysis of crystal packing in the phosphorothioate hexamer, which uses the same P212121 space group as the dodecamer, shows that the highly unsymmetrical B1 vs. BII backbone conformation probably is to be ascribed to crystal packing forces, and not to the sequence of the hexamer.

The primary mode of binding of cisplatin to a B-DNA dodecamer: C-G-C-G-A-A-T-T-C-G-C-G

When cisplatin [cis‐ diamminodichloroplatinum (II)] is diffused into pre‐grown crystals of the B‐DNA double‐helical dodecamer C‐G‐C‐G‐A‐A‐T‐T‐C‐G‐C‐G, it binds preferentially to the N7 positions of guanines, with what probably is an aquo bridge between Pt and the adjacent O6 atom of the same guanine. The entire guanine ring moves slightly toward the platinum site, into the major groove. Only three of the eight potential cisplatin binding sites on guanines actually are occupied, and this differential reactivity can be explained in terms of the relative freedom of motion of guanines toward the major groove. This shift of guanines upon ligation may weaken the glycosyl bond and assist in the depurination that leads to mismatch SOS repair and G.C. to T.A. transversion.

The Major and Minor Grooves of the DNA Helix as Conduits for Information Transfer

The statement that DNA is an informational macromolecule is one that has moved from being an insight, to a commonplace, to dogma, and like so many dogmas has ended as a cliche. But this picture has been given more concrete form in the last six years, with the advent of x-ray crystal structure determinations of synthetic DNA oligomers of defined sequence, both alone and complexed with control proteins such as repressors and with antitumor drugs. It is an attractive idea to a structurally-minded molecular biologist to ask precisely how the information inherent in DNA gets out, in a way that allows it to be used by the host organism.

Rational Design of DNA Minor Groove-Binding Anti-Tumor Drugs

Many of the most useful antitumor drugs act by binding directly to double-helical DNA, interfering with both replication and transcription. Some of these drugs intercalate between adjacent base pairs. A second important class consists of those that bind within the minor groove of B-DNA. These latter tend to show a sequence specificity, binding best to regions of several successive A.T base pairs. We have embarked on a planned course of study of the molecular structures of complexes of such groove-binding drugs with synthetic DNA oligomers, with two goals: to understand the basis for sequence specificity, and to design new drug analogues that are capable of binding specifically to any desired base sequence. Such sequencereading molecules should be capable of being directed against key sequences typical of neoplastic rather than normal cells, or invader rather than host cells. If such molecules become a reality, they should have considerable importance in chemotherapy, directing their action against targeted cells and avoiding some of the more unpleasant side effects associated with chemotherapy.